Moxifloxacin Orion (Moxifloxacin)

Moxifloxacin is a broad‑spectrum fluoroquinolone used to treat infections of the respiratory and other systems.

• Community‑acquired bacterial pneumonia: eradicates the typical pathogens and improves clinical outcomes.
• Acute bacterial sinusitis: reduces sinus inflammation and bacterial load.
• Acute bacterial exacerbation of chronic bronchitis: shortens symptom duration and prevents complications.
• Skin and skin‑structure infections: eliminates susceptible Gram‑positive and Gram‑negative bacteria.
• Intra‑abdominal infections: provides coverage for mixed aerobic and anaerobic organisms.

• Moxifloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By stabilizing the enzyme‑DNA complex, it prevents DNA strand separation, halting bacterial replication and transcription, leading to cell death. This dual targeting confers activity against a wide range of Gram‑positive, Gram‑negative and atypical pathogens.

Moxifloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects

• Nausea: mild gastrointestinal upset.
• Diarrhea: loose stools, often self‑limiting.
• Headache: transient cranial discomfort.
• Dizziness: occasional vertiginous sensation.
• Rash: mild skin erythema or pruritus.
• Elevated liver enzymes: transient laboratory changes.

Serious or Rare Side Effects

• Tendon rupture: sudden pain and loss of function, especially in the Achilles.
• QT interval prolongation: risk of cardiac arrhythmias.
• Severe hypersensitivity: anaphylaxis or Stevens‑Johnson syndrome.
• Clostridioides difficile colitis: severe diarrhea with abdominal pain.
• Peripheral neuropathy: persistent numbness or tingling.
• Hepatotoxicity: significant liver injury with jaundice.

Before prescribing Moxifloxacin, clinicians should consider patient‑specific factors and safety measures.

• Assess cardiac history: avoid in patients with known QT prolongation.
• Review tendon health: contraindicated in patients with recent tendon injury or steroid use.
• Monitor renal function: dose adjustment may be needed in severe impairment.
• Evaluate hepatic status: use with caution in liver disease.
• Avoid in known hypersensitivity: discontinue if allergic reactions occur.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Moxifloxacin can alter the pharmacokinetics of several co‑administered drugs, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: reduce absorption, separate dosing by at least 2 hours.
• Warfarin: may increase INR, monitor coagulation parameters closely.
• Theophylline: increased plasma levels, risk of toxicity.

Moderate Interactions (Monitor Closely)

• CYP1A2 substrates (e.g., caffeine, clozapine): may raise serum concentrations.
• Statins (especially simvastatin): heightened risk of myopathy, consider alternative lipid‑lowering agents.
• Antidiabetic agents (e.g., insulin, sulfonylureas): possible hypoglycemia, monitor glucose levels.